Top Genetic Diagnostics Companies
Golden Helix: Bioinformatics for Advanced Life Science Research

Top 10 Genetic Diagnostics Companies - 2020

Since the last influenza pandemic in 1918, the healthcare system has come a long way today. This is all the more evident from the swift reaction around the recent novel coronavirus outbreak. Even though the COVID-19 pandemic has taken the world by surprise, the global response to the virus outbreak has been prompt and relentless. Amid all this, genetic diagnostic is playing a critical role in identifying and mitigating the viral outbreak.

While CRISPR-based diagnostics development has been gaining traction over the past two years, the current pandemic is bridging the testing gap in the CRISPR revolution. With added impetus from the current pandemic, it may soon break through whatever barriers to commercialization remain. There is also a sharp rise in market demand for PCR, NGS, serology based rapid-test products. From the technological perspective, molecular diagnostics (MDx) and lateral flow assays (LAFs) are also dominating the genetic diagnostics market. And with the demand for quicker tests at community settings, the market is now moving into more point-of-care (POC) devices, including POC MDx and POC LFAs.

To this extent, many companies are bringing forth technology innovations for genetic diagnostics to meet the need for universal and massive testing. On that note, AI and blockchain are two critical technologies that are playing its part in revolutionizing the diagnostic processes. While AI is enabling healthcare professionals to rapidly test millions of DNA and RNA strands in the shortest time possible, blockchain is helping them secure these vast amounts of data and share it among the key stakeholders. Many software companies are also developing algorithms to train machine learning and deep learning to identify signs of aberrations in these data. These rapid changes are now prompting healthcare providers to improve and strengthen their core capabilities and establish strategic partnerships with the best-of-the-breed genetic diagnostic solution providers.

A wide variety of genetic diagnostics companies, at this juncture, are entering the industry with a set of advanced and integrated offerings. Healthcare Tech Outlook has compiled a list of the top 10 genetic diagnostic solution providers. Besides, the magazine also includes insights from thought leaders in the sector on the industry trends, best practices, latest innovations, and their advice for the aspiring CXOs.

We present to you Healthcare Tech Outlook’s, “Top 10 Genetic Diagnostics Companies – 2020.”

    Top Genetic Diagnostics Companies

  • BioDiscovery enables scientists to eliminate disease and suffering through novel application of computational technologies and translating these findings directly and rapidly to clinical use

  • Generate Life Sciences is bridging the gap between life and technology with a spectrum of reproductive and genetic services under one roof for families embarking on their reproductive journey. The company is on a mission to help people build and protect their families through their advanced services starting from the preconception planning phase through birth and into the future. To this end, Generate Life Sciences has brought together the largest and the oldest sperm bank, egg bank, and private stem cell bank to provide people with access to high-quality services needed to confidently build and protect their family’s future. The company also offers genetic testing services, backed by Sema4, a genetic testing and health intelligence company, to add value and actionable information for consumers and healthcare providers

  • Golden Helix provides industry-leading bioinformatics solutions for the advancement of life science research and translational medicine. With a commendable experience of over 20 years in offering industry-leading bioinformatics solutions, the company has built an end-to-end bioinformatics pipeline designed to receive the raw sequencer output and take it to clinical reporting. The architecture provided by Golden Helix supports the thorough analysis of per-sample data coming out of next-generation sequencing machines to the genetic test report stage. Finally, all intermediate and final data is stored in a repository that allows integration to laboratory and hospital record systems through standard protocols and APIs. The company’s technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data products from next-gen sequencers and microarrays

  • Luminus is a full-service specialty lab with an integrated technology platform designed to streamline and enhance patient insights, test ordering, and practice performance

  • PMLS is committed to helping physicians provide the best care to their patients with testing procedures that generate faster results

  • Bionano Genomics

    Bionano Genomics

    At Bionano Genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. Our team is not afraid to venture into uncharted territory to look for answers. We welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. Our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. Saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies

  • Breakthrough Genomics

    Breakthrough Genomics

    Breakthrough Genomics is a pioneer in interpreting Whole Exome, Whole Genome, and Gene Panel Tests. Breakthrough Genomic’s AI/ML powered software platform ENLITER™ is the only Clinical Interpretation Solution designed to mimic the workflow of a U.S. Board-Certified Medical Geneticist. Collectively, the company’s founders have over 60 years of experience directing genomics programs for leading institutions including Illumina, UCLA, and Quest Diagnostics

  • Gravity Diagnostics

    Gravity Diagnostics

    Gravity Diagnostics is an advocate for physicians and patients, supporting them with unsurpassed integrity, regulatory compliance, and clinical expertise. Our pledge to deliver the highest professional operating standards in the laboratory service industry coupled with ongoing research and support exemplifies our commitment to being provider engaged and patient focused

  • Healthcare Datalytics

    Healthcare Datalytics

    Healthcare Datalytics delivers a turn key management solution for labs who have or are interested in providing Hereditary Cancer and Bioinformatic services. We leverage cloud services to increase your throughput capacity leading to new sources of revenue. Our proprietary systems begin with the management and optimization of your Next Generation Sequencing processes utilizing remote automation services to interface with any secondary analysis platform. From there our expert PhD’s conclude with the tertiary analysis and reports customized to your needs

  • Millennium Health

    Millennium Health

    Millennium Health is an accredited specialty laboratory with over a decade of experience delivering timely, accurate, clinically actionable information through our nationwide medication monitoring and drug testing services. Drug testing is used by substance use disorder and pain management providers to obtain objective information about patients’ recent use of prescription medications and/or illicit drugs and helps monitor the effectiveness of treatment plans. We provide best-in-class, compliance-focused solutions through our Urine Drug Testing (UDT) and Oral Fluid Drug Testing (OFT) services. We also offer genetic testing services, including pharmacogenetic testing, that help clinicians make more informed medication choices for their patients. Processing hundreds of thousands of patient specimens each year allows us to provide meaningful insights into emerging drug use trends